The Technical Analyst
Teva Pharmaceutical [TEVJF]
Exchange: OTC Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Teva Pharmaceutical Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $11.75
America/New_York / 19 apr 2024 @ 10:08
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 13 172 mill |
| EPS: | -0.500 |
| P/E: | -23.50 |
| Earnings Date: | May 08, 2024 |
| SharesOutstanding: | 1 120.99 mill |
| Avg Daily Volume: | 0.0019 mill |
| RATING 2024-04-19 |
|---|
| A- |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Buy | |
| Return On Asset: | Buy | |
| DE: | Strong Buy | |
| P/E: | Buy | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -23.50 | sector: PE 29.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.75x |
| Company: PE -23.50 | industry: PE 31.46 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$-3.66 (-131.16%) $-15.41 |
| Date: 2024-04-24 |
| Expected Trading Range (DAY) |
|---|
|
$ 11.57 - 11.93 ( +/- 1.56%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-11-20 | Fox Christine | Buy | 253 968 | Restricted Share Units |
| 2023-11-20 | Fox Christine | Buy | 0 | |
| 2023-11-15 | Conway Vikki L | Buy | 33 482 | Restricted Share Units |
| 2023-11-15 | Bergwerk Dov | Buy | 33 482 | Restricted Share Units |
| 2023-10-13 | Bergwerk Dov | Sell | 0 | Ordinary Shares |
| INSIDER POWER |
|---|
| 23.25 |
| Last 96 transactions |
| Buy: 1 572 847 | Sell: 982 807 |
Forecast: